Wall Street Zen has downgraded LCI Industries (NYSE:LCII) from a "buy" to a "hold" rating, contributing to a consensus "Hold" rating among analysts with an average price target of $154.29. This downgrade comes despite LCI Industries beating quarterly earnings expectations with $0.89 EPS against an expected $0.69 and reporting $932.7 million in revenue. The company also provided a FY 2026 guidance of 8.25–9.25 EPS, but recent insider stock sales, including a significant sale by CEO Jason Lippert, have reduced insider ownership to approximately 3.3%.

Wall Street Zen has upgraded Kingstone Companies (NASDAQ:KINS) from a "hold" to a "buy" rating, contributing to an average "Moderate Buy" rating for the company on MarketBeat. This upgrade follows Kingstone's recent earnings report, which exceeded EPS consensus, and an insider share sale by Director William L. Yankus. The company's financials include a market capitalization of $269.91 million and a P/E ratio of 6.61.

General Motors (GM) stock surged 54% between July 2025 and April 2026, despite a slight revenue dip and halved net income margin. This jump was primarily fueled by a significant increase in its P/E multiple, a reduced share count, a strong 2026 earnings forecast, and a new $6 billion share repurchase authorization. The article highlights the ongoing debate about whether GM's profitable legacy business can fund its EV/AV transition.

Wall Street Zen has upgraded KORU Medical Systems (NASDAQ:KRMD) to a "strong-buy" rating, contributing to a consensus "Moderate Buy" with an average target price of $6.50 among analysts. Despite the company's unprofitability and negative net margin, institutional investors have increased their holdings, with several funds establishing or growing positions in the latest quarter. KORU Medical Systems reported an EPS of ($0.01) and revenue of $10.9 million for the last quarter, surpassing analyst estimates.

Wall Street Zen has upgraded Logitech International (NASDAQ:LOGI) from a "hold" to a "buy" rating, though the broader analyst consensus remains a "Hold" with a target price of $106.29. Logitech recently surpassed Q4 earnings estimates with an EPS of $1.93 and revenue of $1.42 billion, a 6.1% increase year-over-year. The company's stock currently trades around $101, with a market capitalization of $14.8 billion and 45.8% institutional ownership.

Mama's Creations (NASDAQ:MAMA) recently saw its stock rating upgraded from "hold" to "buy" by Wall Street Zen, aligning with other recent upgrades from Zacks and Weiss Ratings. The company reported quarterly earnings per share of $0.05, meeting expectations, and revenue of $53.99 million, exceeding analyst forecasts. Analysts anticipate a 0.09 EPS for the current fiscal year, with the stock currently holding a consensus "Buy" rating and an average price target of $18.80.

Royal Caribbean Group has officially launched the Royal Caribbean Group Foundation, expanding its commitment to global ocean communities. The foundation's initial pledge supports a cutting-edge emergency medicine residency program at Jackson Health System in South Florida. This initiative formalizes the company's philanthropic partnerships, focusing on economic opportunity, community well-being, and environmental stewardship, aligning with its SEA the Future framework.

Wall Street Zen has downgraded Maze Therapeutics (NASDAQ:MAZE) to a "sell" rating, despite other analysts maintaining positive outlooks and a consensus "Buy" rating with a $66 price target. While insiders have sold shares, institutions like Janus Henderson and Vanguard have significantly increased their stakes in the company. Maze Therapeutics currently trades near $28 with a market cap of $1.4 billion.

Analog Devices (ADI) stock shows strong rally potential, with past instances of significant gains, and current catalysts like AI data center acceleration, industrial segment recovery, and broad-based pricing power could drive it to new highs. However, risks such as margin pressure, geopolitical factors, and historical drawdowns during market crises remain relevant. Despite these risks, current fundamentals like revenue growth and cash generation indicate a strong underlying business.

ONEOK, Inc. (NYSE:OKE) has received an average "Moderate Buy" recommendation from eighteen analyst firms, with an average 12-month target price of $89.6875. Several brokerages recently updated their ratings and price targets, including Morgan Stanley, Scotiabank, Wells Fargo, JPMorgan Chase & Co., and UBS Group. The company recently reported strong quarterly earnings, beating analyst estimates, increased its dividend, and analysts expect 2026 EPS to be around $5.07.